PET camera developer Positron is close to completing two dealsthat will put the Houston-based company back on firm financialfooting. The deals are intended to solve a cash crunch that hasdogged Positron since last November. In the first piece of the
PET camera developer Positron is close to completing two dealsthat will put the Houston-based company back on firm financialfooting. The deals are intended to solve a cash crunch that hasdogged Positron since last November.
In the first piece of the financial puzzle, Positron has secureda $1 million revolving line of credit with Boston Financial &Equity that allows the vendor to borrow up to 80% of its accountsreceivables. The financing will give Positron short-term creditflexibility and will enable the company to finance the constructionof PET scanners as it fulfills customer orders, according to CFODavid Rodrigue.
In addition, Positron plans to place up to 2.3 million sharesof preferred stock with private investors. The company hopes toraise between $2 million and $3.5 million with the offering.
Positron will use the funds for working capital and to bringthe company back into compliance with listing requirements forNASDAQ's national market system. Positron has fallen below NASDAQ's$4 million minimum net worth requirement and its stock will bemoved to NASDAQ's small cap market unless it raises more funds.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.